📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Ureidopeptide GLP-1 analogues with prolonged activity in vivo via signal bias and altered receptor trafficking. (2019)

First Author: Fremaux J

Attributed to: Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/c9sc02079a

PubMed Identifier: 32015811

Publication URI: http://europepmc.org/abstract/MED/32015811

Type: Journal Article/Review

Volume: 10

Parent Publication: Chemical science

Issue: 42

ISSN: 2041-6520